असफŎ हॉ˙ीटल 
सबक े िलए ˢा˖ 
 
 
Asarfi Hospital Limited 
Baramuri, P.O.: B Polytechnic, Dhanbad 828 130 || CIN: L85110JH2005PLC011673 
Branch Office: Khatal Road, Dhaiya, ISM, Dhanbad 826004 || www.asarfihospital.com 
Phone: 7808368888, 9234302735 || Email: info@asarfihospital.com 
 
 
AHL/AO/2025/1039        Date: 19.11.2025 
To 
The BSE Limited 
The Listing Department 
25th Floor, Phiroze Jeejeebhoy Towers 
Dalal Street, 
Mumbai – 400001 
Sub: Outcome of Investors/Analysts Meet – Reg. 30(6) of SEBI (LODR) Regulations 
Ref.: Scrip Code – 543943 
Through:  https://ccreservations.com/recordings/select_recordings.php 
Recording ID: 10038307 
Dear Sir/Ma’am, 
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) 
Regulations, 2015, and in continuation of our intimation dated November 15, 2025 regarding the 
schedule of the Institutional Investor/Analyst Meet, we hereby inform you that the Company 
participated in an Investor Meet (one-to-one meeting) organized by Chorus Call Conferencing 
Services (I) Pvt. Ltd. on November 19, 2025 through a virtual platform. 
Mr. Udai Pratap Singh (Managing Director), Mr. Harendra Singh (CFO), Mr. Navin Kumar (VP 
Finance), and Mr. Suraj Hazari (Chief Manager – Finance) participated in the said meeting on behalf 
of the Company. 
We confirm that only information already available in the public domain was shared/discussed during 
the meeting and that no Unpublished Price Sensitive Information (UPSI) was communicated to the 
Institutional Investors/Analysts. 
You are requested to take the above information on record. 
Thanking you, 
Yours faithfully, 
For Asarfi Hospital Limited 
 
(Udai Pratap Singh) 
Managing Director 
DIN: 08453794 
 
 

